Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...
Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Nothing like this has happened in human history. A combination of ...
Zebronics Pro Series Z ZEB-NBC 4S 2023 Laptop (12th Gen Core i5 / 8GB/ 512GB SSD/ Win11 Home) ₹ 34,990 ...
Toshiba U840W-X0310 Satellite U840W-X0310( Intel Core i5 /6GB/500 GB /Integrated Intel HD Graphics 4000/ Windows 7 ) ₹ 53,799 ...